Published in Neurology on August 25, 2010
Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor. Radiology (2012) 1.51
Gray matter imaging in multiple sclerosis: what have we learned? BMC Neurol (2011) 1.03
MS cortical lesions on DIR: not quite what they seem? PLoS One (2013) 0.99
Clinical correlates of grey matter pathology in multiple sclerosis. BMC Neurol (2012) 0.94
Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology. Mult Scler Int (2012) 0.90
Beyond focal cortical lesions in MS: An in vivo quantitative and spatial imaging study at 7T. Neurology (2015) 0.89
Relevance of brain lesion location to cognition in relapsing multiple sclerosis. PLoS One (2012) 0.88
Neuroimaging in multiple sclerosis: neurotherapeutic implications. Neurotherapeutics (2011) 0.85
Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients. PLoS One (2015) 0.83
The role of advanced magnetic resonance imaging techniques in primary progressive MS. J Neurol (2011) 0.81
Grey matter lesions in MS: from histology to clinical implications. Prion (2012) 0.81
Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis. PLoS One (2015) 0.78
DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime? J Neurol Neurosurg Psychiatry (2015) 0.77
Measuring Gray Matter and White Matter Damage in MS: Why This is Not Enough. Front Neurol (2015) 0.77
Spring cleaning: time to rethink imaging research lines in MS? J Neurol (2016) 0.75
Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion. Neurology (2016) 0.75
Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter. PLoS One (2014) 0.75
Toward understanding cortical lesions in multiple sclerosis. Neurology (2010) 0.75
Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS. PLoS One (2016) 0.75
Reliability of cortical lesion detection on double inversion recovery MRI applying the MAGNIMS-Criteria in multiple sclerosis patients within a 16-months period. PLoS One (2017) 0.75
fMRI resting state networks define distinct modes of long-distance interactions in the human brain. Neuroimage (2005) 8.61
Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol (2001) 4.50
Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr (2001) 2.67
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis. Neurology (2011) 2.65
Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology (1995) 2.63
Changes in white matter microstructure during adolescence. Neuroimage (2007) 2.22
Scoring treatment response in patients with relapsing multiple sclerosis. Mult Scler (2012) 2.07
Longitudinal changes in grey and white matter during adolescence. Neuroimage (2009) 2.03
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry (1994) 1.98
Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol (2001) 1.91
The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology (2011) 1.81
Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Mult Scler (2008) 1.70
Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain (1998) 1.68
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. Neurology (2011) 1.68
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology (2009) 1.59
Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J Immunol (1992) 1.59
Increased expression of thyroid hormone receptor isoforms in end-stage human congestive heart failure. J Clin Endocrinol Metab (2001) 1.41
Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. J Exp Med (1988) 1.40
Inflammatory aneurysm of the abdominal aorta. A prospective clinical study. J Cardiovasc Surg (Torino) (1999) 1.39
A pacemaker current in dye-coupled hilar interneurons contributes to the generation of giant GABAergic potentials in developing hippocampus. J Neurosci (1997) 1.37
[Mutism after posterior fossa tumor surgery. Report of 2 cases]. Arq Neuropsiquiatr (1995) 1.37
Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology (2004) 1.36
Class A helix-loop-helix proteins are positive regulators of several cyclin-dependent kinase inhibitors' promoter activity and negatively affect cell growth. Cancer Res (2000) 1.35
Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology (2009) 1.35
The present and the future of neuroimaging in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol (2010) 1.30
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology (2010) 1.27
Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology (2010) 1.27
Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings. Mult Scler (2012) 1.26
Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol (1997) 1.21
Dog bite, Bacteroides infection, coagulopathy, renal microangiopathy. Ann Intern Med (1977) 1.21
Widespread cortical thinning characterizes patients with MS with mild cognitive impairment. Neurology (2010) 1.21
Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. Abdom Imaging (2007) 1.20
Correlates of MS disability assessed in vivo using aggregates of MR quantities. Neurology (2001) 1.20
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology (2008) 1.19
Trade-offs in prenatal detection of Down syndrome. Am J Public Health (1998) 1.15
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis. Neuroimage (2012) 1.15
Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult Scler (2009) 1.15
Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol (1997) 1.15
Electrode positioning for reliable telemetry ECG recordings during social stress in unrestrained rats. Physiol Behav (1996) 1.14
Progressive multiple sclerosis is not associated with chronic cerebrospinal venous insufficiency. Neurology (2011) 1.14
Cortical lesions in radiologically isolated syndrome. Neurology (2011) 1.12
Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol (1998) 1.08
Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study. J Neurol Neurosurg Psychiatry (2011) 1.08
Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis (2000) 1.08
Vagus nerve stimulation modulates cortical synchrony and excitability through the activation of muscarinic receptors. Neuroscience (2011) 1.07
Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey. AIDS Care (2006) 1.07
Valsartan in acute myocardial infarction trial (VALIANT): rationale and design. Am Heart J (2000) 1.06
The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol (1995) 1.06
Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol (2002) 1.06
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis. Mult Scler (2011) 1.05
MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype. Neurology (2009) 1.04
Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. Exp Brain Res (2008) 1.04
Genetic heterogeneity of megalencephalic leukoencephalopathy and subcortical cysts. Neurology (2003) 1.04
Development of a new geometric bicycle saddle for the maintenance of genital-perineal vascular perfusion. J Sex Med (2005) 1.04
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. J Neurol (2012) 1.04
A computerized data bank of surgical pathology and cytopathology diagnoses. Structure and purposes. Virchows Arch A Pathol Anat Histopathol (1983) 1.03
Home palliative care as a cost-saving alternative: evidence from Catalonia. Palliat Med (2001) 1.02
Cirrhosis: value of caudate to right lobe ratio in diagnosis with US. Radiology (1986) 1.02
Case report of heterotopic bone formation in metastatic carcinoma of the colon. Tumori (1979) 1.01
Oxidative phosphorylation defect in the brains of carriers of the tRNAleu(UUR) A3243G mutation in a MELAS pedigree. Ann Neurol (2000) 1.01
Tumour necrosis factor-alpha in infectious meningitis. Arch Dis Child (1989) 1.01
Myocyte transdifferentiation: a possible pathogenetic mechanism for arrhythmogenic right ventricular cardiomyopathy. Arch Pathol Lab Med (2000) 1.01
Ultrasound-guided fine needle biopsy of the spleen: high clinical efficacy and low risk in a multicenter Italian study. Am J Hematol (2001) 1.01
Muscarinic M2 and M1 receptors reduce GABA release by Ca2+ channel modulation through activation of PI3K/Ca2+ -independent and PLC/Ca2+ -dependent PKC. J Neurophysiol (2007) 1.00
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. Mult Scler (2009) 0.99
Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection. J Am Coll Cardiol (1994) 0.98
A Rett syndrome MECP2 mutation that causes mental retardation in men. Neurology (2002) 0.98
Reproducibility of fMRI in the clinical setting: implications for trial designs. Neuroimage (2008) 0.98
EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis. Eur J Neurol (2006) 0.97
Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology (2000) 0.95
Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study. Mult Scler (2008) 0.95
The CDK9-associated cyclins T1 and T2 exert opposite effects on HIV-1 Tat activity. AIDS (1999) 0.95
Disseminated mycobacterial infection in AIDS patients: abdominal US features and value of fine-needle aspiration biopsy of lymph nodes and spleen. Abdom Imaging (2003) 0.94
Cryosurgery in bronchoscopic treatment of tracheobronchial stenosis. Indications, limits, personal experience. Chest (1993) 0.94
T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry (2010) 0.94
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. Neurology (2012) 0.93